Literature DB >> 15616257

Early insulin therapy for type 2 diabetic patients: more cost than benefit.

Mayer B Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616257     DOI： 10.2337/diacare.28.1.222

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

Review 1.  Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment.

Authors:  Vivian A Fonseca; Michelle A Haggar
Journal:  Nat Rev Endocrinol       Date:  2014-02-18       Impact factor: 43.330

2.  Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.

Authors:  M Peyrot; A H Barnett; L F Meneghini; P-M Schumm-Draeger
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

3.  Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia.

Authors:  Alireza Mirahmadizadeh; Hamed Delam; Mozhgan Seif; Sayed Aliakbar Banihashemi; Hamidreza Tabatabaee
Journal:  Iran J Med Sci       Date:  2019-05

Review 4.  Early insulin treatment in type 2 diabetes: what are the pros?

Authors:  Luigi F Meneghini
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.